The Week’s 10 Biggest Funding Rounds: NinjaOne Leads With $400M As Large Deals Also Go To Blockchain, Cloud Infrastructure, Biotech And Robotics
NinjaOne leads with a $400M Series C extension in enterprise software. Digital Asset secures $355M for blockchain tech.
Intelligence analysis by Qwen 2.5 (3B)
This week's top 10 funding rounds include large deals in enterprise software, blockchain, AI cloud infrastructure, biotech, and robotics.
This week, some big companies got lots of money to keep growing their businesses. One company called NinjaOne got $400 million to help run computer stuff better. Another company named Digital Asset got $355 million for making special computer networks that can do tricky math problems really fast. Other companies got money too, like one that makes medicine and another that uses satellites in space.
Analysis
NinjaOne
- Company: NinjaOne
- Industry: Enterprise Software
- Funding Round: Series C extension
- Amount Raised: $400M
- Valuation: $12.3B
- Details: NinjaOne, an IT operations and endpoint management platform provider, reported a 70% revenue growth in 2025 and posted a profit in Q1 2026.
Digital Asset
- Company: Digital Asset
- Industry: Blockchain Technology
- Funding Round: Later-stage financing
- Amount Raised: $355M
- Details: Founded in 2014, the New York-based company has raised at least $847 million in known funding.
TensorWave
- Company: TensorWave
- Industry: AI Cloud Infrastructure
- Funding Round: Series B
- Amount Raised: $350M
- Details: Las Vegas-based provider of AMD AI cloud technology for training and inference workloads, led by Magnetar Capital and AMD Ventures.
Beren Therapeutics
- Company: Beren Therapeutics
- Industry: Biotech
- Funding Round: Equity and debt funding
- Amount Raised: $300M
- Details: Thousand Oaks-based company includes $165 million in debt from Hercules Capital and $135 million in equity investment.
Standard Bots
- Company: Standard Bots
- Industry: Robotics
- Funding Round: Series C
- Amount Raised: $200M
- Details: New York-based manufacturer of AI-native industrial robots, led by RoboStrategy and General Catalyst.
SonoThera
- Company: SonoThera
- Industry: Genetic Medicines
- Funding Round: Series B
- Amount Raised: $125M
- Details: San Francisco-based developer of ultrasound-mediated genetic medicine platform, led by Vida Ventures.
GT Medical Technologies and MainFunc (aka Genspark)
- Companies: GT Medical Technologies & MainFunc
- Industry: Medical Devices & Agentic AI
- Funding Round: Series E/B
- Amount Raised: $100M each
- Details: Tempe-based developer of radiation therapy and agentic AI tools, led by Viking Global Investors and investors including Sozo Ventures.
City Therapeutics
- Company: City Therapeutics
- Industry: Biotech
- Funding Round: Series B
- Amount Raised: $99.5M
- Details: Cambridge-based developer of RNAi-based medicines, led by Viking Global Investors and Sofinnova Investments.
Rylo
- Company: Rylo
- Industry: Tools for the Deaf and Hearing-Impaired
- Funding Round: Growth funding
- Amount Raised: $85M
- Details: San Francisco-based developer of an app for hearing-impaired people, led by General Catalyst and Canaan.
Neura Robotics and Iceye
- Companies: Neura Robotics & Iceye
- Industry: Robotics & Space Tech
- Funding Round: Series C/F
- Amount Raised: $1.4B/$520M respectively
- Details: Germany-based developer of AI infrastructure for robots and Finnish space tech operator, led by General Atlantic.
Key points
- NinjaOne raised $400M for its IT management platform
- Digital Asset got $355M to improve blockchain technology
- TensorWave closed a $350M Series B round for AI cloud services
- Beren Therapeutics secured $300M for their genetic medicine research
- Standard Bots raised $200M for industrial robots
These big investments show that investors trust these startups to grow their businesses successfully. This could lead to more innovation and new products for people to use.
But if some of the companies don't manage well, they might not be able to keep growing with all this money. Also, sometimes getting too much money can make a company lose focus or spend it in ways that aren't good for them.
